Year: 2021

COVISTIX maintains its ability to detect the Omicron Variant, in addition to detecting SARS-CoV-2 and all of its major variants of concern (VoCs); COVISTIX has the potential to be a “Best-in-Class” rapid COVID-19 virus antigen detection test:Comparative studies with all available EUA-approved COVID-19 virus rapid antigen detection tests demonstrated that COVISTIX significantly outperforms in terms of limit of detection (LOD) of the N proteins and/or live viruses of SARS-CoV-2 and its major VoCs; and In a large in-field real-world clinical study for all-comers including asymptomatic patients, COVISTIX demonstrated approximately 20% higher sensitivity vs. a leading global brand (detailed results can be found at: https://www.medrxiv.org/content/10.1101/2021.09.10.21263410v1);COVISTIX is currently approved and marketed in Mexico, Brazil...

SAN DIEGO, Dec. 27, 2021 (GLOBE NEWSWIRE) — Retail Opportunity Investments Corp. (NASDAQ:ROIC) announced today the release of its annual Environmental, Social and Governance (ESG) report. The report is available at: https://investor.roicreit.com. HIGHLIGHTS7% reduction in same-center greenhouse gas emissions 5% reduction in same-center energy consumption Awarded 2021 Green Lease Leader (“Gold” designation) by U.S. Department of Energy Commenced comprehensive Environmental Management System program Enhanced reporting regarding key sustainability and climate-related disclosures 100% corporate participation in annual diversity, equity and inclusion training Continued employee community environmental engagement initiatives Added three new, diverse independent directors to Board of Directors Enhanced corporate governance (amended...

SAN DIEGO, Dec. 27, 2021 (GLOBE NEWSWIRE) — Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with gastrointestinal and liver diseases, today announced that Hubert C. Chen, M.D., chief medical officer, has resigned to pursue a new opportunity. Dr. Chen’s resignation is effective December 31, 2021. Preston Klassen, M.D., MHS, chief executive officer, is expected to assume responsibility for Metacrine’s ongoing clinical trials and future clinical operations. “We appreciate Hubert’s significant contributions during the last three years as we moved our pipeline through several important milestones,” said Preston Klassen, M.D., MHS, CEO, Metacrine. “Hubert has established a strong team in our R&D organization that will continue to serve us well as we focus...

ROCKVILLE, Md., Dec. 27, 2021 (GLOBE NEWSWIRE) — Capital Bancorp, Inc., (NASDAQ: CBNK) (“Capital” or “Company”) the holding company of Capital Bank, N.A. (the “Bank”), continues its proud tradition of strong leadership with the announcement of new board member Jerome Bailey. Bailey is a member of the Bank’s board and managing member of Bailey Real Estate Holdings, LLC in Washington, D.C., and has been a leader in the multifamily, affordable housing industry in the D.C. area for nearly two decades. “We are pleased to have Jerome Bailey join us on the holding company board. Over the years, he has proven himself a seasoned and capable entrepreneur starting his own real estate development company while focusing on his many philanthropic initiatives to uplift the community in which he lives,”...